SARS-CoV-2 Pseudovirus Neutralization Assay

DC David H Canaday
OO Oladayo A Oyebanji
DK Debbie Keresztesy
MP Michael Payne
DW Dennis Wilk
LC Lenore Carias
HA Htin Aung
KD Kerri St. Denis
EL Evan C Lam
CR Christopher F Rowley
SB Sarah D Berry
CC Cheryl M Cameron
MC Mark J Cameron
BW Brigid M Wilson
AB Alejandro B Balazs
CK Christopher L King
SG Stefan Gravenstein
ask Ask a question
Favorite

To determine the neutralizing activity of vaccine recipients’ sera against coronaviruses, we produced lentiviral particles pseudotyped with spike protein based on the Wuhan strain as previously described [8]. Briefly, neutralization assays were performed using a Fluent 780 liquid handler (Tecan) in 384-well plates (Grenier). Three-fold serial dilutions that ranged from 1:12 to 1:8748 were performed and added to 50–250 infectious units of pseudovirus for 1 hour. pNT50 values were calculated by taking the inverse of the 50% inhibitory concentration value for all samples with a pseudovirus neutralization value of 80% or higher at the highest concentration of serum. The lower limit of detection (LLD) of this assay is 1:12 dilution.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A